CompletedPhase 3NCT02713945
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
Studying Noonan syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Thomas Edouard, MD, PHDChildren's Hospital, Toulouse University Hospital
- Intervention
- Simvastatin(drug)
- Enrollment
- 53 target
- Eligibility
- 6-16 years · All sexes
- Timeline
- 2017 – 2023
Study locations (12)
- CHU Angers Unité d'endocrinologie pédiatrique, Angers, France
- CHU Bordeaux Unité de Génétique pédiatrique, Bordeaux, France
- Chu Dijon, Dijon, France
- CHRU Lille Unité d'endocrinologie pédiatrique, Lille, France
- CHU Lyon Unité d'endocrinologie pédiatrique, Lyon, France
- CHU Marseille La Timone Unité d'Endocrinologie pédiatrique, Marseille, France
- Chu Montpellier, Montpellier, France
- CHU Nancy Unité de Génétique pédiatrique, Nancy, France
- Hôpital Robert Debré Unité de Génétique pédiatrique, Paris, France
- Hôpital Trousseau Unité d'endocrinologie pédiatrique, Paris, France
- CHU Rennes Unité de Génétique pédiatrique, Rennes, France
- CHU Toulouse Hôpital des Enfants, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02713945 on ClinicalTrials.govOther trials for Noonan syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07464821National Multicentre Study on Lipid Profile in Noonan Syndrome and Related Disorders: Trends by Age, Gender and GenotypeIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT06555237MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathiesMedical University of Warsaw
- ENROLLING BY INVITATIONNCT05308927French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan SyndromeNovo Nordisk A/S
- RECRUITINGNCT05202210Constitution of a Biological Collection to Study the Pathophysiology in Noonan SyndromeUniversity Hospital, Toulouse